These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 316389)

  • 1. The biochemistry of the citrovorum factor rescue effect in normal bone marrow cells after high-dose methotrexate.
    Sauer H; Schalhorn A; Wilmanns W
    Eur J Cancer (1965); 1979 Oct; 15(10):1203-9. PubMed ID: 316389
    [No Abstract]   [Full Text] [Related]  

  • 2. Biochemical control of high-dose methotrexate/Leucovorin rescue therapy.
    Wilmanns W; Sauer H; Schalhorn A
    Recent Results Cancer Res; 1980; 74():42-9. PubMed ID: 6969415
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Radiational basis and practice of the citrovorum factor (Leucovorin) protection after high-dose methotrexate therapy. High-dose methotrexate/leucovorin].
    Sauer H; Schalhorn A
    Onkologie; 1980 Apr; 3(2):64-71. PubMed ID: 6994007
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biochemistry of the citrovorum factor rescue effect in normal bone marrow cells after high-dose methotrexate treatment: implications for therapy.
    Wilmans W; Sauer W; Schalhorn A
    Recent Results Cancer Res; 1978; 68():33-9. PubMed ID: 313587
    [No Abstract]   [Full Text] [Related]  

  • 5. [High-dose methotrexate/leucovorin adjuvant chemotherapy of osteogenic sarcoma: biochemical effects in DNA-synthesis of bone marrow cells (author's transl)].
    Sauer H; Wilmanns W
    Blut; 1978 Jun; 36(6):357-61. PubMed ID: 306851
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma amino acids during high-dose methotrexate-citrovorum "rescue".
    Hilton MA; Kmetz DR; Patel CC
    Biochem Med; 1976 Aug; 16(1):9-15. PubMed ID: 1087560
    [No Abstract]   [Full Text] [Related]  

  • 7. Favorable response of metastatic osteogenic sarcoma to pulse high-dose methotrexate with citrovorum rescue and radiation therapy.
    Jaffe N; Paed D; Farber S; Traggis D; Geiser C; Kim BS; Das L; Frauenberger G; Djerassi I; Cassady JR
    Cancer; 1973 Jun; 31(6):1367-73. PubMed ID: 4541163
    [No Abstract]   [Full Text] [Related]  

  • 8. Cytokinetic comparison of thymidine and leucovorin rescue of marrow in humans after exposure to high-dose methotrexate.
    Howell SB; Krishan A; Frei E
    Cancer Res; 1979 Apr; 39(4):1315-20. PubMed ID: 311245
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Letter: Methotrexate with citrovorum-factor rescue.
    Falk L
    N Engl J Med; 1975 Jun; 292(26):1406-7. PubMed ID: 1079571
    [No Abstract]   [Full Text] [Related]  

  • 10. "Single"-agent activity of high-dose methotrexate with citrovorum factor rescue.
    Von Hoff DD; Rozencweig M; Louie AC; Bender RA; Muggia FM
    Cancer Treat Rep; 1978 Feb; 62(2):233-5. PubMed ID: 305823
    [No Abstract]   [Full Text] [Related]  

  • 11. Effects of methotrexate on deoxyribonucleotide pools and nucleic acid synthesis in human osteosarcoma cells.
    Skoog L; Nordenskjöld B; Humla S; Hägerström T
    Eur J Cancer (1965); 1976 Oct; 12(10):839-45. PubMed ID: 1067967
    [No Abstract]   [Full Text] [Related]  

  • 12. Methotrexate megadosage followed by folate rescue. I. A study in clearance patterns.
    Salasoo S; Irving MG; Lam-Po0Tang R; O'Gorman-Hughes D; Freedman A
    Med J Aust; 1976 May; 1(21):777-9. PubMed ID: 1085404
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of high-dose methotrexate with citrovorum factor "rescue" in the treatment of osteogenic sarcoma.
    Jaffe N; Traggis D; Cassady JR; Filler RM; Watts H; Frei E
    Int J Radiat Oncol Biol Phys; 1977; 2(3-4):261-6. PubMed ID: 301137
    [No Abstract]   [Full Text] [Related]  

  • 14. "Rescue" techniques in cancer chemotherapy: use of leucovorin and other rescue agents after methotrexate treatment.
    Bertino JR
    Semin Oncol; 1977 Jun; 4(2):203-16. PubMed ID: 301662
    [No Abstract]   [Full Text] [Related]  

  • 15. [Methotrexate-leucovorin rescue therapy: pharmacological characteristics and clinical effective use].
    Fujimoto T
    Gan To Kagaku Ryoho; 1996 Dec; 23(14):1901-6. PubMed ID: 8978794
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of high-dose methotrexate with citrovorum factor on human granulopoiesis.
    Schremi W; Lohrmann HP
    Cancer Res; 1979 Oct; 39(10):4195-9. PubMed ID: 314330
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The influence of liver and renal functions on the changes in serum methotrexate (MTX) level in high-dose MTX therapy].
    Sato T; Nakanishi K; Takahashi M; Sato K; Miura T; Kuzuya T; Mizuno M
    Gan To Kagaku Ryoho; 1990 Dec; 17(12):2375-9. PubMed ID: 2260874
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relative biochemical aspects of low and high doses of methotrexate in mice.
    Zaharko DS; Fung WP; Yang KH
    Cancer Res; 1977 Jun; 37(6):1602-7. PubMed ID: 870175
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High-dose methotrexate with citrovorum factor rescue: predictive value of serum methotrexate concentrations and corrective measures to avert toxicity.
    Nirenberg A; Mosende C; Mehta BM; Gisolfi AL; Rosen G
    Cancer Treat Rep; 1977 Aug; 61(5):779-83. PubMed ID: 302143
    [No Abstract]   [Full Text] [Related]  

  • 20. Progress report on high-dose methotrexate (NSC-740) with citrovorum rescue in the treatment of metastatic bone tumors.
    Jaffe N
    Cancer Chemother Rep; 1974; 58(2):275-80. PubMed ID: 4598245
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.